XRAY
DENTSPLY·NASDAQ
--
--(--)
--
--(--)
9.71 / 10
Outperform
XRAY's fundamental analysis is robust, scoring 9.7/10. Key strengths include favorable Cash-MV (0.13) and Cash-UP (0.19) values, an impressive Net profit / Total profit (%) of 133.63, and a healthy Interest coverage ratio (15.48%). However, persistent revenue declines and negative Asset-MV (-0.50) and ROA (-7.94%) readings temper enthusiasm. These factors collectively earn a Fundamental rating of Outperform, indicating solid long-term value despite some profitability concerns.
Analysis Checks(5/10)
Revenue-MV
Value1.10
Score1/3
Weight-40.35%
1M Return-1.83%
Value1.10
Score1/3
Weight-40.35%
1M Return-1.83%
Net profit attributable to parent company shareholders / Net profit (%)
Value99.78
Score1/3
Weight-84.32%
1M Return-3.49%
Value99.78
Score1/3
Weight-84.32%
1M Return-3.49%
Cash-UP
Value0.19
Score3/3
Weight119.35%
1M Return3.93%
Value0.19
Score3/3
Weight119.35%
1M Return3.93%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-45.96%
1M Return-1.95%
Value15.48
Score2/3
Weight-45.96%
1M Return-1.95%
Cash-MV
Value0.13
Score2/3
Weight102.67%
1M Return3.31%
Value0.13
Score2/3
Weight102.67%
1M Return3.31%
ROA (%)
Value-7.94
Score1/3
Weight-14.78%
1M Return-0.54%
Value-7.94
Score1/3
Weight-14.78%
1M Return-0.54%
Net income-Revenue
Value-0.17
Score1/3
Weight-57.55%
1M Return-2.55%
Value-0.17
Score1/3
Weight-57.55%
1M Return-2.55%
Annualized net profit margin on total assets (%)
Value-10.59
Score1/3
Weight-14.78%
1M Return-0.54%
Value-10.59
Score1/3
Weight-14.78%
1M Return-0.54%
Asset-MV
Value-0.50
Score3/3
Weight101.59%
1M Return3.31%
Value-0.50
Score3/3
Weight101.59%
1M Return3.31%
Net profit / Total profit (%)
Value133.63
Score3/3
Weight34.13%
1M Return1.20%
Value133.63
Score3/3
Weight34.13%
1M Return1.20%
Revenue-MV
Value1.10
Score1/3
Weight-40.35%
1M Return-1.83%
Value1.10
Score1/3
Weight-40.35%
1M Return-1.83%
ROA (%)
Value-7.94
Score1/3
Weight-14.78%
1M Return-0.54%
Value-7.94
Score1/3
Weight-14.78%
1M Return-0.54%
Net profit attributable to parent company shareholders / Net profit (%)
Value99.78
Score1/3
Weight-84.32%
1M Return-3.49%
Value99.78
Score1/3
Weight-84.32%
1M Return-3.49%
Net income-Revenue
Value-0.17
Score1/3
Weight-57.55%
1M Return-2.55%
Value-0.17
Score1/3
Weight-57.55%
1M Return-2.55%
Cash-UP
Value0.19
Score3/3
Weight119.35%
1M Return3.93%
Value0.19
Score3/3
Weight119.35%
1M Return3.93%
Annualized net profit margin on total assets (%)
Value-10.59
Score1/3
Weight-14.78%
1M Return-0.54%
Value-10.59
Score1/3
Weight-14.78%
1M Return-0.54%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-45.96%
1M Return-1.95%
Value15.48
Score2/3
Weight-45.96%
1M Return-1.95%
Asset-MV
Value-0.50
Score3/3
Weight101.59%
1M Return3.31%
Value-0.50
Score3/3
Weight101.59%
1M Return3.31%
Cash-MV
Value0.13
Score2/3
Weight102.67%
1M Return3.31%
Value0.13
Score2/3
Weight102.67%
1M Return3.31%
Net profit / Total profit (%)
Value133.63
Score3/3
Weight34.13%
1M Return1.20%
Value133.63
Score3/3
Weight34.13%
1M Return1.20%
Is XRAY undervalued or overvalued?
- XRAY scores 9.71/10 on fundamentals and holds a Discounted valuation at present. Backed by its -26.43% ROE, -24.31% net margin, -3.11 P/E ratio, 1.86 P/B ratio, and -116.75% earnings growth, these metrics solidify its Outperform investment rating.
